bf/NASDAQ:ICUI_icon.png

COM:ICUMED

ICU Medical

  • Stock

USD

Last Close

158.33

14/02 21:00

Market Cap

3.88B

Beta: -

Volume Today

83.23K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
35.69M
-
40.28M
12.86%
46.45M
15.31%
168.96M
263.76%
299.91M
77.50%
324.40M
8.17%
326.28M
0.58%
302.58M
7.26%
493.12M
62.97%
702.68M
42.50%
average payables
11.36M
-
12.52M
10.28%
14.16M
13.03%
46.43M
228.03%
99.35M
113.95%
124.55M
25.37%
100.25M
19.51%
76.50M
23.69%
148.51M
94.15%
182.97M
23.20%
average receivables
42.18M
-
48.45M
14.85%
57.00M
17.66%
137.88M
141.88%
208.02M
50.87%
199.33M
4.18%
163.16M
18.15%
114.99M
29.52%
163.81M
42.45%
191.64M
16.99%
book value per share
33.26
-
36.59
10.02%
40.83
11.59%
61.09
49.62%
61.96
1.42%
66.76
7.75%
71.85
7.63%
76.21
6.06%
87.56
14.90%
88.14
0.66%
capex per share
-1.15
-
-0.88
23.62%
-1.52
72.71%
-4.06
167.51%
-4.94
21.64%
-5.14
4.02%
-4.80
6.59%
-3.83
20.29%
-4.16
8.72%
-3.48
16.32%
capex to depreciation
-0.90
-
-0.77
14.77%
-1.29
67.16%
-1.20
7.13%
-1.35
12.66%
-1.24
7.71%
-1.06
14.95%
-0.90
14.51%
-0.42
53.32%
-0.37
13.19%
capex to operating cash flow
-0.29
-
-0.25
12.46%
-0.27
7.48%
-0.52
89.02%
-0.63
21.90%
-1.04
65.41%
-0.45
56.68%
-0.30
32.68%
1.60
626.96%
-0.50
131.57%
capex to revenue
-0.06
-
-0.04
28.31%
-0.06
58.69%
-0.06
4.75%
-0.07
16.77%
-0.08
16.34%
-0.08
5.69%
-0.06
21.93%
-0.04
29.35%
-0.04
14.76%
cash per share
22.69
-
23.81
4.95%
55.06
131.20%
15.30
72.21%
18.74
22.44%
14.19
24.29%
19.65
38.51%
26.75
36.14%
8.92
66.64%
10.57
18.48%
days of inventory on hand
85.40
-
99.00
15.93%
101.03
2.06%
121.59
20.35%
136.83
12.54%
155.15
13.38%
142.00
8.47%
128.44
9.55%
160.56
25.01%
170.42
6.14%
days payables outstanding
26.31
-
31.02
17.89%
30.03
3.19%
32.95
9.74%
52.98
60.77%
59.10
11.57%
32.40
45.18%
35.90
10.80%
49.81
38.73%
36.04
27.63%
days sales outstanding
46.09
-
61.80
34.08%
54.03
12.56%
62.01
14.76%
51.21
17.41%
58.29
13.83%
35.64
38.87%
29.36
17.60%
35.49
20.88%
26.10
26.46%
debt to assets
0.01
-
-0.00
127.56%
0.02
838.39%
0.03
38.01%
0.02
18.99%
0.37
1,428.66%
0.37
1.60%
debt to equity
0.01
-
-0.00
127.68%
0.03
823.21%
0.03
31.85%
0.03
19.70%
0.79
2,738.05%
0.77
3.04%
dividend yield
earnings yield
0.02
-
0.03
19.62%
0.03
5.21%
0.02
38.81%
0.01
62.05%
0.03
325.71%
0.02
25.99%
0.02
5.78%
-0.02
196.45%
-0.01
37.55%
enterprise value
975.78M
-
1.45B
48.72%
1.94B
33.50%
3.95B
103.72%
4.34B
9.93%
3.63B
16.38%
4.14B
14.13%
4.53B
9.30%
5.20B
14.98%
3.78B
27.40%
enterprise value over ebitda
14.21
-
12.81
9.82%
14.60
13.93%
57.69
295.14%
22.77
60.52%
24.44
7.31%
30.30
23.97%
31.85
5.12%
22.98
27.85%
165.49
620.22%
ev to operating cash flow
16.09
-
26.45
64.37%
21.54
18.57%
25.56
18.65%
27.08
5.95%
35.59
31.45%
18.59
47.78%
16.91
9.00%
-83.75
595.14%
22.73
127.14%
ev to sales
3.16
-
4.25
34.61%
5.11
20.23%
3.05
40.21%
3.10
1.49%
2.87
7.54%
3.26
13.70%
3.44
5.53%
2.28
33.62%
1.67
26.73%
free cash flow per share
2.82
-
2.58
8.31%
4.04
56.59%
3.81
5.78%
2.91
23.52%
-0.20
106.86%
5.85
3,029.04%
8.79
50.16%
-6.76
176.97%
3.42
150.51%
free cash flow yield
0.03
-
0.02
33.42%
0.03
19.86%
0.02
35.72%
0.01
28.06%
-0.00
108.41%
0.03
2,655.28%
0.04
35.71%
-0.04
216.00%
0.03
179.74%
graham net net
23.67
-
24.96
5.49%
56.43
126.04%
15.83
71.95%
17.81
12.54%
14.44
18.91%
19.13
32.41%
24.86
29.95%
-71.16
386.29%
-63.28
11.07%
graham number
35.91
-
48.34
34.62%
59.87
23.85%
69.36
15.85%
44.37
36.03%
85.77
93.33%
81.96
4.45%
91.32
11.42%
78.31
14.25%
49.41
36.90%
income quality
2.30
-
1.22
47.03%
1.43
16.90%
2.25
57.79%
5.56
147.35%
1.01
81.87%
2.56
154.20%
2.59
1.16%
0.84
67.76%
-5.60
770.11%
intangibles to total assets
0.02
-
0.05
207.24%
0.04
18.19%
0.10
162.83%
0.09
12.53%
0.14
57.18%
0.13
8.96%
0.12
5.61%
0.54
337.08%
0.54
0.64%
interest coverage
-7.37
-
30.48
513.83%
115.15
277.78%
23.85
79.29%
61.05
155.99%
-0.13
100.21%
-0.24
82.80%
interest debt per share
0.91
-
-0.19
121.02%
1.78
1,035.18%
2.58
44.49%
2.16
16.03%
72.05
3,228.47%
63.66
11.65%
inventory turnover
4.27
-
3.69
13.74%
3.61
2.02%
3.00
16.91%
2.67
11.14%
2.35
11.80%
2.57
9.26%
2.84
10.56%
2.27
20.01%
2.14
5.79%
invested capital
0.01
-
-0.00
127.68%
0.03
823.21%
0.03
31.85%
0.03
19.70%
0.79
2,738.05%
0.77
3.04%
market cap
1.25B
-
1.79B
42.80%
2.38B
33.29%
4.24B
77.83%
4.68B
10.54%
3.86B
17.57%
4.48B
16.17%
5.03B
12.24%
3.76B
25.32%
2.40B
36.07%
net current asset value
404.36M
-
458.05M
13.28%
524.56M
14.52%
565.97M
7.89%
605.30M
6.95%
567.06M
6.32%
659.35M
16.28%
765.10M
16.04%
-1.19B
255.60%
-1.03B
13.17%
net debt to ebitda
-4.02
-
-2.97
26.09%
-3.35
13.00%
-4.24
26.41%
-1.81
57.32%
-1.57
13.49%
-2.52
60.74%
-3.57
41.99%
6.38
278.50%
60.22
844.01%
net income per share
1.72
-
2.84
64.72%
3.90
37.46%
3.50
10.30%
1.41
59.66%
4.90
246.90%
4.16
15.16%
4.86
17.05%
-3.11
163.99%
-1.23
60.45%
operating cash flow per share
3.97
-
3.46
12.75%
5.56
60.69%
7.87
41.53%
7.86
0.22%
4.94
37.11%
10.65
115.65%
12.62
18.41%
-2.60
120.63%
6.90
365.03%
payables turnover
13.87
-
11.77
15.18%
12.16
3.29%
11.08
8.88%
6.89
37.80%
6.18
10.37%
11.26
82.41%
10.17
9.74%
7.33
27.92%
10.13
38.18%
receivables turnover
7.92
-
5.91
25.42%
6.76
14.37%
5.89
12.86%
7.13
21.08%
6.26
12.15%
10.24
63.57%
12.43
21.36%
10.28
17.27%
13.98
35.98%
research and ddevelopement to revenue
0.06
-
0.05
22.41%
0.03
25.75%
0.04
16.11%
0.04
4.77%
0.04
1.67%
0.03
11.98%
0.04
6.79%
0.04
13.02%
0.04
7.37%
return on tangible assets
0.05
-
0.08
52.53%
0.09
23.59%
0.05
45.08%
0.02
60.96%
0.07
248.73%
0.06
18.71%
0.06
10.41%
-0.04
157.00%
-0.01
59.13%
revenue per share
20.24
-
21.56
6.53%
23.46
8.84%
65.90
180.86%
68.65
4.17%
61.38
10.59%
60.79
0.96%
62.07
2.10%
95.53
53.89%
93.77
1.83%
roe
0.05
-
0.08
49.72%
0.10
23.18%
0.06
40.05%
0.02
60.23%
0.07
221.96%
0.06
21.18%
0.06
10.37%
-0.04
155.70%
-0.01
60.71%
roic
0.05
-
0.08
50.13%
0.09
21.95%
-0.02
117.86%
0.02
232.88%
0.04
73.88%
0.02
39.63%
0.03
10.86%
-0.00
105.75%
0.00
255.90%
sales general and administrative to revenue
0.29
-
0.01
98.17%
0.24
4,379.33%
0.24
0.24%
0.23
0.32%
shareholders equity per share
33.26
-
36.59
10.02%
40.83
11.59%
61.09
49.62%
61.96
1.42%
66.76
7.75%
71.85
7.63%
76.21
6.06%
87.56
14.90%
88.14
0.66%
stock based compensation to revenue
0.03
-
0.04
21.04%
0.04
7.02%
0.01
62.74%
0.02
15.65%
0.02
0.03%
0.02
8.88%
0.02
10.21%
0.02
23.93%
0.02
13.64%
tangible asset value
499.71M
-
549.47M
9.96%
632.20M
15.05%
1.04B
64.85%
1.12B
7.38%
1.13B
1.39%
1.27B
12.11%
1.38B
8.82%
-342.10M
124.71%
-219.62M
35.80%
tangible book value per share
32.70
-
34.67
6.03%
39.10
12.78%
53.13
35.88%
54.87
3.27%
55.00
0.23%
60.84
10.62%
65.28
7.29%
-14.33
121.96%
-9.12
36.39%
working capital
408.48M
-
462.39M
13.20%
528.56M
14.31%
654.37M
23.80%
677.75M
3.57%
633.73M
6.49%
725.29M
14.45%
829.03M
14.30%
740.64M
10.66%
739.43M
0.16%

All numbers in USD (except ratios and percentages)